Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis
Laura Giusti1, Laura Bazzichi, Chiara Baldini
1Department of Psychiatry, University of Pisa, Pisa, Italy.
The Journal of Rheumatology
|August 28, 2007
Summary
This proteomic study reveals distinct salivary protein profiles in systemic sclerosis (SSc) patients compared to healthy individuals. Key proteins identified may serve as novel diagnostic markers or therapeutic targets for SSc.
Area of Science:
- Biochemistry
- Proteomics
- Immunology
Background:
- Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis and vascular abnormalities.
- Salivary dysfunction is a common manifestation in SSc patients, but detailed protein alterations are not well understood.
Purpose of the Study:
- To investigate global changes in salivary protein profiles of patients with systemic sclerosis (SSc) using a proteomic approach.
- To identify potential biomarkers for SSc diagnosis and therapy.
Main Methods:
- Whole saliva (WS) was collected from 15 SSc patients and 15 healthy controls.
- Proteomic analysis involved 2D gel electrophoresis and peptide mass fingerprinting for protein identification.
Main Results:
- Qualitative differences in salivary protein profiles were observed between SSc patients and controls.
- Nine unique proteins, including cyclophilin A, calgranulin B, psoriasin, beta2-microglobulin, and triose phosphate isomerase (TPI), were identified in SSc patients' saliva.
- Proteins such as keratin 6L, psoriasin, TPI, and Arp2/3 complex may hold pathological significance for SSc.
Conclusions:
- This is the first study to report WS protein patterns in SSc patients using proteomics.
- The identified proteins, both known and novel, suggest potential roles in SSc pathogenesis.
- Certain salivary proteins could be developed as new diagnostic markers or therapeutic targets for SSc.
